Antimicrobials
Colistin

Colistin

Restricted

Medium
N/A
IV: $$$$

General Information

Not funded

  • Nephrotoxicity (18% to 26%)

  • Renal: Acute renal failure (33% to 60%)

  • Central nervous system: Neurotoxicity (7%)

    • Lexicomp Colistimethate Monograph
  • CBC with differential, renal function tests, urine output
  • Monitor for neurologic effects (e.g. paresthesia, seizures, slurred speech, vertigo)
  • Number and type of stools/day for diarrhea
  • For inhalation therapy: Pre- and post-treatment spirometry
  • Monitor for signs of allergic reactions (e.g. wheezing, chest tightness, fever, swelling of face, lips or tongue)

Supplied by Pharmacy in a syringe as a ready-to-administer solution, in a concentration of 75 mg colistin base/mL

  • Monitor for neurologic and renal adverse effects with IV use
  • Avoid concomitant use with other nephrotoxic medications
  • Possible alternative therapy: Tobramycin